Insulin and C-Peptide Levels After Oral and Intravenous Glucose: Contribution of Enteroinsular Axis to Insulin Secretion

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Diabetes

• Publication date

  1986-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diab.35.5.612PMID 3514335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic beta cell secretion during oral and intravenous glucose administration.

  2009cited by this paper
• The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man

  2004cited by this paper
• Enteroinsular axis.

  1988cited by this paper
• C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

  1984cited by this paper
• Comparison of peripheral glucose uptake after oral glucose loading and a mixed meal.

  1983cited by this paper
• Oral glucose decreases hepatic extraction of insulin.

  1983cited by this paper
• Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous Glucose

  1983cited by this paper
• Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.

  1983cited by this paper
• [Radioimmunoassay of gastric inhibitory polypeptide].

  1983cited by this paper
• Nervous regulation of insulin release by the intestinal vagal glucoreceptors.

  1981cited by this paper
• THE EFFECT OF INCREASING DOSES OF INGESTED GLUCOSE ON INSULIN AND GASTRIC INHIBITORY POLYPEPTIDE (GIP) CONCENTRATIONS IN MAN

  1980cited by this paper
• Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man

  1979cited by this paper
• The incretin concept today

  1979cited by this paper
• Radioimmunoassay of Gastric Inhibitory Polypeptide

  1978cited by this paper
• C-peptide Metabolism and the Liver

  1978cited by this paper
• Insulin response and portal-peripheral insulin difference during the oral glucose tolerance test in patients after abdominal operations.

  1976cited by this paper
• Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

  1976cited by this paper
• The Glucose‐Induced Gastrointestinal Stimulation of Insulin Secretion in Man: Relation to Age and to Gastrin Release

  1975cited by this paper
• Extraction of insulin by liver.

  1973cited by this paper
• Intestinal factors in the control of insulin secretion.

  1965cited by this paper
• PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.

  1964cited by this paper
• NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

  1964cited by this paper
• Insulin Assay in Insulinomas

  1963cited by this paper
• STUDIES ON CARBOHYDRATE METABOLISM I. SOME COMPARISONS OF BLOOD SUGAR CONCENTRATIONS IN VENOUS BLOOD AND IN FINGER BLOOD

  1923cited by this paper

• GLP-1 and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal?

  2026cites this paper
• Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response

  2025cites this paper
• Investigation of glucagon-like peptide-1 response to six oral carbohydrates in ponies.

  2024cites this paper
• Vincent Marks (10 June 1930 to 6 November 2023)

  2023cites this paper
• Genetic variants of the GLP-1R gene affect the susceptibility and glucose metabolism of gestational diabetes mellitus: a two-center nested case‒control study

  2022cites this paper
• Influence of various fat sources on the glucose, insulin and incretin concentration in healthy cats

  2020cites this paper
• Effects of isoenergetic quantities of a low‐starch muesli feed high in fat and fibre vs. oat grains on the glycemic and insulinemic responses and feed intake patterns in sport ponies

  2017cites this paper
• Relationships between diet, obesity and insulin dysregulation in horses and ponies

  2016cites this paper
• The effect of oral and intravenous dextrose on C-peptide secretion in ponies.

  2016cites this paper
• Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation.

  2016cites this paper
• Postprandial glucose, insulin, and glucagon-like peptide-1 responses of different equine breeds adapted to meals containing micronized maize.

  2015cites this paper
• Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy.

  2015cites this paper
• Gut as an Endocrine Organ: The Role of Nutrient Sensing in Energy Metabolism

  2011cites this paper
• ENTEROINSULAR AXIS: PHYSIOLOGY AND PATHOPHYSIOLOGY. METABOLIC AND PLEIOTROPIC EFFECTS OF INCRETINS

  2009cites this paper
• Incretin release from gut is acutely enhanced by sugar but not by sweeteners in vivo.

  2009cites this paper
• The impact of diabetic autonomic neuropathy on the incretin effect.

  2008cites this paper
• Mechanism-Based Modeling of the Glucose-Insulin Regulation during Clinical Provocation Experiments

  2008cites this paper
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

  2008cites this paper
• New treatments for type 2 diabetes mellitus: combined therapy with sitagliptin

  2008cites this paper
• Intravenous glucose administration in fasting rats has differential effects on acylated and unacylated ghrelin in the portal and systemic circulation: a comparison between portal and peripheral concentrations in anesthetized rats.

  2007cites this paper
• An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics

  2007cites this paper
• Exenatide: A Novel Approach for Treatment of Type 2 Diabetes

  2006cites this paper
• Intestinal peptides and ethnic differences in insulin secretion

  2006cites this paper
• Gut hormones in glucose homeostasis

  2005cites this paper
• Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice

  2005cites this paper
• Atypical antipsychotics and glucose homeostasis.

  2005cites this paper
• NUTRIENT REGULATION OF THE ENTERO- INSULAR AXIS A N D INSULIN SECRETION

  2005cites this paper
• Physiological endocrine control of energy homeostasis and postprandial blood glucose levels.

  2005cites this paper
• The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion

  2004cites this paper
• First-phase insulin secretion: does it exist in real life? Considerations on shape and function.

  2004cites this paper
• Harnessing the gut to treat diabetes

  2004cites this paper
• Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation

  2004cites this paper
• The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).

  2003cites this paper
• Insulin release in impaired glucose tolerance: oral minimal model predicts normal sensitivity to glucose but defective response times.

  2002cites this paper
• Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone secretion in humans

  2002cites this paper
• Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).

  2001cites this paper
• Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus).

  2001cites this paper
• Glucose-dependent insulinotropic hormone potentiates the hypoglycemic effect of glibenclamide in healthy volunteers: evidence for an effect on insulin extraction.

  2001cites this paper
• Glucagon and Glucagon‐like Peptide Production and Degradation

  2001cites this paper
• Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.

  2001cites this paper
• Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity

  2001cites this paper
• Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.

  2000cites this paper
• Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats.

  1999cites this paper
• GIP biology and fat metabolism.

  1999cites this paper
• The role of gastrointestinal hormones in carbohydrate and lipid metabolism and homeostasis: effects of gastric inhibitory polypeptide and glucagon-like peptide-1.

  1998cites this paper
• Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH‐deficient adults

  1998cites this paper
• Short chain fatty acids, intestinal adaptation, and nutrient utilization.

  1997cites this paper
• Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism

  1996cites this paper
• Wege der Nachrichtenübermittlung bei der Stimulation der Sekretion von Insulin

  1996cites this paper
• Effects of Glucose Ingestion Versus Infusion on Pulsatile Insulin Secretion: The Incretin Effect Is Achieved by Amplification of Insulin Secretory Burst Mass

  1996cites this paper
• [Routes to normalization in the stimulation of insulin secretion].

  1996cites this paper
• The Measurement of Cognitive Function During Acute Hypoglycaemia: Experimental Limitations and Their Effect on the Study of Hypoglycaemia Unawareness

  1996cites this paper
• Relative Fasting Hypoinsulinaemia and Ultrasonically Measured Early Arterial Disease in Type 2 Diabetes

  1996cites this paper
• The metabolic role of GIP: physiology and pathology.

  1996cites this paper
• Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats.

  1996cites this paper
• Post-heparin plasma lipase activity in hypopituitary adults.

  1995cites this paper
• Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults

  1995cites this paper
• Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.

  1995cites this paper
• Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia.

  1995cites this paper
• The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

  1995cites this paper
• Diurnal variation of sex hormone binding globulin and insulin‐like growth factor binding protein‐1 in women with polycystic ovary syndrome

  1995cites this paper
• Hyperinsulinemia and hypertension. Do intestinal hormones play a role?

  1995cites this paper
• In vivo and in vitro effects of gamma-linolenic acid and eicosapentaenoic acid on prostaglandin production and arachidonic acid uptake by human endometrium.

  1994cites this paper
• Reduced Postprandial Energy Expenditure in Women Predisposed to Type 2 Diabetes

  1994cites this paper
• How to measure insulin clearance.

  1994cites this paper
• Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients.

  1993cites this paper
• The incretin notion and its relevance to diabetes.

  1993cites this paper
• The Effects of Glibenclamide on Glucose Homeostasis and Lipoprotein Metabolism in Poorly Controlled Type 2 Diabetes

  1993cites this paper
• 9 – METABOLIC EFFECTS OF GUT PEPTIDES

  1992cites this paper
• Normoglycemia per se but not normoinsulinemia is responsible for suppressing endogenous insulin secretion after oral glucose load in NIDDM.

  1992cites this paper
• Gut hormones and diabetes mellitus.

  1992cites this paper
• Insulinotropic glucagonlike peptide-I(7-37)/(7-36)amide A new incretin hormone.

  1992cites this paper
• Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.

  1992cites this paper
• [Various molecular mechanisms involved in the pathogenesis of type II diabetes and their potential therapeutic importance].

  1992cites this paper
• Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells.

  1992cites this paper
• The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes

  1992cites this paper
• Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.

  1992cites this paper
• Evaluation of GIP and intestinal GLP-1(7-36)amide function in hyperphagic states

  1992cites this paper
• per se but not normoinsulinemia is responsible endogenous insulin secretion after oral glucose load in NIDDM

  1992cites this paper
• Effects of truncated glucagon-like peptide-1 on the responses of starved sheep to glucose.

  1991cites this paper
• Plasma Glucose and Insulin Response to Macronutrients in Nondiabetic and NIDDM Subjects

  1991cites this paper
• Feedback inhibition of insulin secretion in type 2 diabetes.

  1991cites this paper
• The Influence of Regional Adiposity on Atherogenic Risk Factors in Men and Women with Type 2 Diabetes

  1991cites this paper
• Gut Hormones in Glucose Homeostasis

  1991cites this paper
• The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes

  1991cites this paper
• The role of the entero-insular axis in insulin secretion.

  1990cites this paper
• The Role of Cholecystokinin and Other Gut Peptides on Regulation of Postprandial Glucose and Insulin Levels

  1990cites this paper
• The effect of a time delay on the characteristics of the canine glucoregulatory system.

  1990cites this paper
• Endocrine pancreatic secretion in patients after acute pancreatitis.

  1990cites this paper
• Decreased C-peptide secretion in sickle cell anemia.

  1989cites this paper
• A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.

  1989cites this paper
• Hyperinsulinemia; a mediator of decreased food intake and weight loss in anorexia nervosa and major depression.

  1989cites this paper
• Insulin, Glucagon and Catecholamine Responses to the Ingestion of Various Carbohydrates

  1989cites this paper
• Plasma glucose and insulin responses to oral and intravenous glucose in cold-exposed humans.

  1988cites this paper
• Role of gastric inhibitory polypeptide in postprandial hyperinsulinemia of obesity.

  1988cites this paper
• Nutrient Regulation of the Enteroinsular Axis And Insulin Secretion

  1988cites this paper
• Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet

  1988cites this paper
• Incretin Effect Due to Increased Secretion and Decreased Clearance of Insulin in Normal Humans

  1988cites this paper
• Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition.

  1987cites this paper
• Blood glucose and plasma insulin responses to fat free milk and low-lactose fat free milk in healthy human volunteers

  1987cites this paper